ALXN

46 Stock Bellwethers on the Move

There is no doubt the upcoming first-quarter earnings announcement season is going to separate the wheat from the chaff and here are 46 stocks with new ratings More

Bull’s Eye Report: Regeneron Pharmaceuticals (REGN)

Looking for a non-correlated asset to beat the market in a potential downturn? Look no further than biotech stock Regeneron Pharmaceuticals (REGN). More

Bull’s Eye Report: Regeneron Pharmaceuticals (REGN)

REGN gained 208.65% on the year in 2012, and while normally this would indicate a parabolic run, the short-term prospects for a trade still look pretty good. More

Put Credit Spread on Alexion Pharmaceuticals Inc. (ALXN)

Here is a trade idea that considers a continued bullish trend, but also has a double back-up plan just in case. More

5 Funds That Will Profit From Mega-Trends

Rather than stock-picking to profit off today's major trends, investors can improve their chances by buying into these mutual funds and ETFs. More

Grade My Top 5 Buys for 2012

Early this year, I shared with you my 2012 Profit Playbook video and discussed my top five stocks for the New Year. Let's take a closer look at how we've done More